Brief: Calidi Biotherapeutics To Present New Preclinical Data Highlighting Cell-Based Virotherapy (Supernova) Platform Technology
10/10/2023 12:57
Oct 10 (Reuters) - Calidi Biotherapeutics Inc CLDI.A :
* CALIDI BIOTHERAPEUTICS TO PRESENT NEW PRECLINICAL DATA
HIGHLIGHTING CELL-BASED VIROTHERAPY (SUPERNOVA) PLATFORM
TECHNOLOGY AT SITC 2023
Source text for Eikon: ID:nBwgfTxSa
Further company coverage: CLDI.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Calidi Biotherapeutics
See all newsBrief: Calidi Biotherapeutics Announces Strategic Partnership With Transferai
Brief: Calidi Biotherapeutics Announces Partnership With Avance Clinical To Facilitate Australian Regulatory Approval
Brief: Calidi Biotherapeutics Announces Pricing Of $5.2 Million Underwritten Public Offering
Brief: Calidi Biotherapeutics Eliminates Chief Legal Officer Position - SEC Filing
Brief: Calidi Biotherapeutics Receives FDA Fast Track Designation For Cld-201 (Supernova), A First-In-Class Stem-Cell Loaded Viral Therapy For The Treatment Of Patients With Soft Tissue Sarcoma